Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune resetCandid’s lead asset, cizutamig, a bispecific ...

Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears on behalf of the United States defending a CMS program ...

The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology ...

Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per monthBrief Summary:GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per ...

Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS ...

Oral argument heard Friday, May 1, 2026 in Smart Approaches to Marijuana v. Kennedy — with Ilya Shapiro arguing for ...

DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced ...

LINCOLN, NE / ACCESS Newswire / May 1, 2026 / Securitas Healthcare, a leading provider of real‑time visibility and protection ...

AltaLink is monitoring extreme wildfire conditions forecast for Sunday, May 3, within the Municipal District of Provost No.

Following a recent FSDPA speaking engagement, the Tampa-area dermatologist continues a spring schedule of community health initiatives and dermatology education across Florida. TAMPA, FL / ACCESS ...

UCB acquires IMIDomics’ Patient Insight Business, gaining access to one of the world’s most comprehensive multi omic datasets for immune mediated inflammatory diseasesPatient Insight Business enhances ...

The global hearing aids market is projected to grow at a rate of 6–7% over the next five years. This growth is driven by ...